Compare SXT & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXT | INDV |
|---|---|---|
| Founded | 1882 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.4B |
| IPO Year | 1994 | 2014 |
| Metric | SXT | INDV |
|---|---|---|
| Price | $110.71 | $39.58 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $121.00 | N/A |
| AVG Volume (30 Days) | 528.9K | ★ 1.6M |
| Earning Date | 04-24-2026 | 06-08-2026 |
| Dividend Yield | ★ 1.36% | N/A |
| EPS Growth | 7.48 | ★ 8100.00 |
| EPS | ★ 1.04 | 0.69 |
| Revenue | ★ $1,396,499,000.00 | $1,239,000,000.00 |
| Revenue This Year | $8.99 | N/A |
| Revenue Next Year | $9.45 | N/A |
| P/E Ratio | $104.63 | ★ $58.72 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $82.60 | $15.91 |
| 52 Week High | $129.35 | $42.81 |
| Indicator | SXT | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 49.11 |
| Support Level | $110.12 | $39.20 |
| Resistance Level | $127.07 | $41.00 |
| Average True Range (ATR) | 3.29 | 1.42 |
| MACD | -1.48 | -0.21 |
| Stochastic Oscillator | 13.28 | 15.85 |
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are: Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).